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ABSTRACT
Introduction: Infective endocarditis presents a high rate of morbidity and mortality. Population-based studies addressing mortality 
caused by infective endocarditis in Portugal are scarce. We aimed to study deaths caused by Infective endocarditis, as well as cor-
responding demographics and temporal trends.
Material and Methods: Retrospective cohort study of all patients whose main cause of death was Infective endocarditis in Portugal 
from 2002 to 2018. The data was obtained from the national death certificate information system.
Results: In Portugal, 3634 people died from infective endocarditis throughout the 17-year study period - infective endocarditis specific 
mortality rate of 2.1 per 100 000 habitants. Of all deceased, 89% were at least 60 years old, and most were women (55%). Overall, 
72% died in a healthcare institution. An annual 9% increase in the incidence death rate from Infective endocarditis was observed, with 
a significant upward trend during the colder months.
Discussion: In Portugal, mortality by infective endocarditis increased, mainly affecting older patients and women, and which can 
partially be explained by factors such as ageing of the population. The management of older patients with infective endocarditis is chal-
lenging as they present a higher number of comorbidities, more valvular heart disease and valve implants, invasive medical procedures 
and are less likely to undergo cardiac surgery.
Conclusion: In addition to data on the evolution of demographics in Portugal, it is crucial to study the incidence of infective endocarditis 
over time to help explain these findings. The identification of factors that can be used to better model national health policies to improve 
clinical outcomes of infective endocarditis in Portugal is also required.
Keywords: Endocarditis/epidemiology; Endocarditis/mortality; Portugal; Seasons
RESUMO
Introdução: A endocardite infeciosa apresenta uma taxa substancial de morbilidade e mortalidade. Estudos populacionais que abor-
dam a mortalidade por endocardite infeciosa em Portugal são escassos. O nosso objetivo foi estudar as mortes causadas por endo-
cardite infeciosa e os dados demográficos e tendências temporais correspondentes.
Material e Métodos: Estudo de coorte retrospetivo de todos os doentes cuja causa de óbito foi endocardite infeciosa em Portugal 
entre 2002 e 2018. Os dados foram obtidos no sistema nacional de informação de certificados de óbito.
Resultados: Em Portugal, 3634 pessoas morreram de endocardite infeciosa ao longo de um período de 17 anos - taxa de mortalidade 
específica da endocardite infeciosa de 2,1 por 100 000 habitantes. De todos os falecidos, 89% tinham pelo menos 60 anos, a maior 
parte dos quais do género feminino (55%) e morreram por endocardite infeciosa. Globalmente, 72% morreram numa instituição de 
saúde. Foi demonstrado um aumento anual de 9% na taxa de mortalidade por endocardite infeciosa, com uma tendência ascendente 
significativa nos meses mais frios.
Discussão: Em Portugal, a mortalidade por endocardite infeciosa aumentou, afetando principalmente doentes mais idosos e mulhe-
res, o que pode ser parcialmente explicado pelo envelhecimento da população. O manejo de doentes idosos com endocardite infe-
ciosa é exigente, pois apresentam maior número de comorbidades, mais valvulopatia e próteses valvulares, procedimentos médicos 
invasivos e menor probabilidade de serem submetidos a cirurgia cardíaca.
Conclusão: Para além dos dados sobre a evolução demográfica de Portugal, é indispensável rever a incidência da endocardite infe-
ciosa e a sua tendência, de forma a melhor interpretar estes resultados. É fundamental identificar indicadores que possam ser usados 
para melhor modelar as políticas nacionais de saúde, de forma a melhorar os resultados clínicos na endocardite infeciosa no nosso 
país.
Palavras-chave: Endocardite/epidemiologia; Endocardite/mortalidade; Estações; Portugal
INTRODUCTION
 Infective endocarditis (IE), an inflammatory process affecting the valves, endocardium and/or intracardiac prosthetic 
material, and is often caused by bacteria. A high incidence of morbidity and mortality related to complicated IE has been 
described.1
 Worldwide, IE has an estimated annual incidence rate of 3 - 10 per 100 000 people.2 Several studies3–6 reported an 
increasing incidence over time. This is likely due to an ageing population, as well as other factors such as a higher 
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prevalence of structural valve disease, prosthetic valves or intracardiac devices and comorbidities (diabetes, hemodialysis, 
HIV) or a high rate of invasive medical procedures.
 Despite improvement in diagnosis and medical/surgical treatment, most centers report an intrahospital mortality around 
20%.7 Indeed, multiple series have reported an increasing trend for this indicator in several developed countries such as 
France,5 Italy4 or England.8 On the other hand, Finland9 and Sweden10 showed no significant changing trends, while Toyoda 
et al6 concluded that the mortality rate due to IE decreased in the United States of America between 1998 and 2013. Never-
theless, intrahospital mortality for IE is high, as reported in international series with 12.6% in the Euro Heart Survey,11 18% 
in the ICE study,12 or 17.1% in the recent EURO-ENDO registry.13 
 Portugal has had a significant reduction in the mortality attributed to cardiovascular disease14 in all age groups in the 
last 20 years, predominantly related to a reduction in death attributed to ischemic heart disease. However, there is scarce 
data available regarding IE-related mortality.15 
 In this study, we aimed to address this lack of data in Portugal, with a population-based analysis involving fatal IE and 
to specifically evaluate temporal trends, age and gender differences. 
MATERIAL AND METHODS
Study design and data source
 A nationwide retrospective observational study on fatal IE was performed using data from the National Institute of Sta-
tistics (Instituto Nacional de Estatística – INE) in Portugal, from January 2002 to December 2018. All data used in this study 
is publicly available and was obtained directly from the INE’s internet portal (https://www.ine.pt/xportal/xmain?xpgid=ine_
main&xpid=INE&xlang=pt) or through the use of the email info@ine.pt for data request. 
 This data is based on information used for statistical purposes from the Civil Registry Integrated System (Sistema Inte-
grado do Registo e Identificação Civil - SIRIC) and the Death Certificate Information System (Sistema de Informação dos 
Certificados de Óbito - SICO), covering all deaths, residents and non-residents, occurring in the country.
 The death certificate is mandatory by law and is issued by a trained physician identifying the main cause of death 
and other secondary clinical diagnoses that contributed to death. For the studied period, only the basic clinical diagnosis 
causing death (“illness or injury that initiated the chain of pathological events that led to death or the circumstances of the 
accident or violence that produced the fatal injury”) could be collected.
 After 2002, the coding of causes of death according to the International Statistical Classification of Diseases and 
Related Health Problems, 10th Revision (ICD-10) version has been used and is carried out by the Portuguese Directorate-
General of Health.16
 For the identification of IE as the cause of death, we used codes I33, I38 and I39 (ICD-10).  
Study population and variables
 The population in each year was obtained from census population (2001 and 2011) and from estimates for intercensal 
years, at INE’s database. The estimated population was 10 444 592 in 2002, increasing to 10 573 479 in 2009 and decreas-
ing to 10 276 617 in 2018.17
 Portuguese national all-cause mortality data for the period 2002 - 2018 was also obtained from INE,18 the number of 
deaths varied between 102 363 (2006) and 113 573 (2018), with the crude mortality rate varying between 9.69 (2006) and 
10.99 (2018) per 1000 habitants.
 All deaths caused by IE were assessed and stratified by gender and age groups (20-year interval groups, 0 - 19, 20 - 
39, 40 - 59, 60 - 79, ≥ 80). Death location (healthcare institution vs home) was also collected, as well as data on whether 
medical autopsy was carried out.
 The following indicators were analyzed: proportion of deaths with IE as cause of death (% of total deaths by specific 
cause); gender; location of death (healthcare institution vs home); crude death rate by gender and 20-year interval age 
groups; standardized mortality rate (all ages) for the European 2013 standard population19 performed by the direct meth-
od.20
 The study used anonymized public domain data and therefore ethics committee approval was not required.
Statistics
 Continuous variables are presented as mean ± standard deviation and categorical variables expressed as frequencies 
and percentages. We assessed the trends in annual death rate standardized to the 2013 census population.
 To assess temporal trends and the effect of age, gender and seasonality, we compared different regression models, 
including Poisson, negative binomial and corresponding zero-inflation regression models. We used Akaike’s information 
criteria to compare different model structures and likelihood ratio tests to compare nested models with different covari-
ates.21 We used ‘age group’, gender’, ‘month’ and ‘season’ as potential covariates. The regression results are presented 
using rate ratios and corresponding 95% confidence intervals (CI).
 The data was analyzed using IBM SPSS Statistics for Windows version 24, except for the regression models that were 
done with R,22 with the following packages MASS22 for the negative binomial models and pscl23 for zero-inflated models.
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RESULTS
Demographic features of patients who died of IE in Portugal 
 From 2002 to 2018, IE was documented as the cause of death in 3634 patients. Demographic data is depicted in Table 
1.
 Fatal cases of IE were lowest in the group ≤ 19 years old and increased with increasing patient age, with 89% of the 
deaths occurring in individuals 60 years old and older.
 A growing number of deaths among patients with at least 60 years of age was noted throughout the 17-year study 
period, with a higher increase noted from 2010 onwards in patients 80 years old and over, exceeding those aged 60 - 79 
years old (Fig.1).
 Of the total deaths, 1624 (44.7%) were males (M) and 2010 (55.3%) were females (F) and the ratio male/female was 
on average 0.84 (min. 0.62 – max. 1.1) per year, during the study period. 
 Among individuals 60 years of age and older, there were more female than male deaths, while the opposite was noted 
amongst younger patients (Fig. 2).
Mortality by IE in Portugal
 IE was responsible on average for 2 out of 1000 deaths in Portugal, during the study period.
 The standardized mortality (using the European 2013 standard population) rate due to IE in Portugal was on average 
2.1 per 100 000 habitants, with an increasing trend for the period analyzed from 1.0 (2002) to 3.8 (2018) per 100 000 habi-
tants (Fig. 3). 
 The proportion of deaths per IE to the total number of deaths of circulatory disease increased from 0.3 in 2002 to 1.2 in 
2018. These results were driven by a reduction in the total number of deaths resulting from circulatory diseases in general 
(mortality rate due to circulatory diseases was 391 per 100 000 habitants in 2002 and decreased to 318 per 100 000 habi-
tants in 2018), in line with an increase in the number of deaths by IE in the same period (Table 2).
 Additionally, considering all years, men had a lower mortality rate for IE (1.9) than female patients (2.2). However, this 
difference between male and female patients only became clear over the last decade (Fig. 4 and Table 2).
 IE specific mortality rate was lower in younger patients and increased gradually with age (Table 3). Comparing deaths 
caused by IE with total deaths in the Portuguese population, the highest contribution of IE was in the group 60 - 79 years 
old, decreasing slightly in patients over 80 years old.
Mortality according to place of death
 Analysis on the place of death indicates that 71.9% died in a healthcare institution and 22.9% died at home. The re-
maining 5.2% of cases did not have information on place of death. Regardless of the place, the percentage of death in 
women was higher (this difference was more pronounced when considering deaths at home) than in men. Across all age 
groups, deaths in healthcare institutions were more prevalent (Fig. 5).
 Medical autopsy confirming the diagnosis was available only for 104 death certificates (2.9% of the total cohort).
Temporal and seasonal effects on the deaths by IE
 To study the evolution of the number of deaths due to IE in Portugal, we tested different model structures (see Methods) 
with the dependent variable ‘number of deaths’ each month from 2002 to 2018. We evaluated the temporal trend over that 
period, as well as the effect of gender, age group and season. The best model structure was a negative binomial, although 
a Poisson regression model gave essentially the same rate ratio estimates. To analyze the effect of season, we first used 
a preliminary model with ‘month’ as covariate. We found that the number of deaths increased in December, January, Feb-
ruary and March, compared with the other months. Therefore, we defined two ‘seasons’: a winter period including those 
months, and the rest of the year. This shorter model was as good as the full model with individual months. The results of 
this regression are presented in Table 4. 
 The final variables included in the model, ‘year’, ‘age group’, ‘gender’ and ‘season’, were all highly significant and mod-
els without any one of these were statistically inferior, using a likelihood ratio test. We found an approximate 9% increase in 
incidence per year, since 2002. This estimate had very narrow confidence intervals. Women had a 19% higher incidence of 
death compared to men. The incidence increased substantially with older age groups, and this was very significant, despite 
wide confidence intervals in these estimates. Finally, we found a lower incidence (of approximately 20%) during the warmer 
months of the year, from April to November.
DISCUSSION
 This is the first nationwide study analyzing deaths associated with IE in Portugal and four main findings were obtained 
from this analysis. First, the standardized mortality rate for IE was 2.1 per 100 000 inhabitants, with an annual increasing 
trend. Second, most deaths occurred in patients who were at least 60 years old. Third, there were more deaths of female 

















































patients than male patients. Finally, mortality by IE was higher during the colder months.
 The overall IE standardized mortality rate increased steadily from 1 to 3.8 per 100 000 people over the period of the 
study, 2002 to 2018. Data obtained from Instituto Nacional de Estatística revealed a consistent increase in IE specific mor-
tality over this period, with an annual increase averaging about 9%. As a comparison, IE incident death rate in Finland24 
was lower (1.42 per 100 000 habitants) and there was no significant changing trend between 2004 and 2016. The inci-
dence of IE in Portugal has not been estimated, and if it is increasing, it could be an important aspect helping to explain the 
increase seen in mortality. This is especially important, because nationwide studies from Denmark25 and Italy4 have shown 
an increasing incidence of IE, which could impact on mortality. This increased incidence could be explained by several 
factors including ageing of the population, a higher use of intracardiac devices, cardiac valve prosthesis implantation and 
invasive medical procedures in a population with more comorbidities. A more debilitated population with IE could account 
for an increase in deaths by this disease. Likewise, the present analysis included a timeframe with significant changes in IE 
prophylaxis, improvement in IE diagnosis with newer techniques (improved microbiologic detection, 3D echocardiography 
and PET/CT imaging) and surgical intervention timing26 that could have impacted on the mortality of these patients. Note 
that a dramatic decrease in Portugal’s cardiovascular disease mortality and years of life lost has been demonstrated27,28 
(this is due to diagnostic and therapeutic improvements of ischemic heart disease and cerebrovascular disease), which 
translated in a decrease in mortality due to circulatory diseases in the studied period, contrasting with an increasing trend 
in the mortality by endocarditis.
 Despite deaths caused by IE occurring in all considered age groups, almost 90% of the deceased were 60 years old 
or older, which is in agreement with other series4,12,13,29–32 and from 2010 onwards octogenarians were in fact the most 
prevalent age-group. The elderly present more comorbidities, more heart valve disease and valve implants,33,34 are subject 
to more invasive medical procedures, are less likely to undergo cardiac surgery35 and age has been shown to be an inde-
pendent risk factor for mortality36 in IE.
 All these findings could partly be explained by Portuguese demographic trends. Indeed, the population in Portugal has 
experienced a gradual increase in life expectancy37,38 with a sustained increase in the aging index of the population,39 with 
concomitant exacerbation of the comorbidities due to population aging .  
 Worldwide, in population-based studies of incident IE,40 men are usually more affected. Paradoxically, in our study, 
women who have a higher life expectancy37 (in Portugal, women live on average six years longer than men) and are also 
in greater number in the Portuguese population,17 had a higher mortality in the setting of IE with a ratio male/female vary-
ing between 0.6 and 1.1 - this comparison is more pronounced in older patients (over 60 years of age). This is probably 
explained by the fact that gender may, indeed, be an additional risk factor for IE mortality.13,32,41 Moreover, gender variations 
regarding comorbidities, frailty index, treatment biases and physiologic differences may explain this contradictory finding.42 
 Nearly 3% of patients that died due to IE underwent a medical autopsy – indeed, autopsy continues to be an important 
tool in identifying clinically missed IE and in unveiling the multisystemic involvement and complications that may emerge 
from IE. Nevertheless, hospital series report fatal IE cases in 1% - 1.5% of autopsies,43,44 meaning that only a minor frac-
tion of cases are diagnosed after death occurs. Despite a paucity of data regarding the frequency which IE is found in 
autopsies,44 it is a crucial method of clinical research. Nearly 23% of subjects died at home, which is unexpected as IE is 
a complex disease with almost universal hospitalization, and the number of autopsies is clearly lower than this rate. Newly 
diagnosed fatal IE with sudden death identified in an autopsy is one explanation. Data concerning previous hospitalization, 
or the treatment regimen, was not available and therefore the reasons that could potentially explain the remaining cases 
are speculative. Still, this finding could be related to patients with a very recent hospitalization for acute IE, on outpatient 
parenteral antibiotic course, or waiting for cardiac surgery, or in patients that were referred for palliative care.
 A 2017 meta-analysis45 including twenty five observational studies, estimated  short and long term follow-up (six months 
up to 10 years) mortality rate of 20% and 37%, respectively. Data on long term outcomes of IE in population-based and 
observational studies are limited – the  5-year mortality rate described by Fernandez-Hidalgo et al46 and Toyoda et al47 was 
around 50%. Alarmingly, long-term outcomes have shown to be poor, even in patients who have survived and have been 
discharged from hospital after an IE event.48 This may probably explain why we have found that one fifth of deaths occurred 
outside a healthcare institution. Other factors that could partially contribute to this high rate is the diagnosis of IE through 
autopsy in deaths occurring outside a hospital.
 Finally, there is scarce data on the impact of seasonal variation on deaths for IE.49 Indeed, seasonal mortality varia-
tion has been described in other conditions such as heart failure,50,51 sepsis,52 cardiovascular and all-cause mortality.53,54 
In our study, a 20% mortality decrease was noted during the warmer months. Reasons for this result remain speculative, 
but should take into account not only exposure to cold, but also socio-economic conditions,55 or immunologic response 
with cold temperatures related to melatonin secretion56 and leukocyte function.57 Finkelhor58 detected a higher fall/winter 
predominance of the diagnosis of IE with echocardiography, with an impact on incidence and, possibly, mortality as well.
Limitations of the study 
 One must consider that this is a retrospective study based on administrative data using coded information. Reliable 
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and uniform diagnosis is always an issue. Coding errors could also have occurred, and there is no possibility to review 
clinical data, case by case. Nevertheless, death certificates are issued by trained physicians, which guarantees the qual-
ity of the presented data. Furthermore, no data exists concerning the population with IE and its characteristics such as 
demographics, comorbidities, microbiology, procedures or surgical interventions that could help explain our findings re-
garding mortality rate and its temporal trends. Additionally, codes I38 and I39 can include non-infective forms of IE such as 
Libmann-Sachs. Finally, as previously mentioned, there is currently no published data on the incidence of IE incidence in 
Portugal, which would be crucial for this discussion.
CONCLUSION
 IE has a mortality rate estimated at 2.1 per 100 000 people, with an increasing trend of around 9% annually. A seasonal 
variation was noted, with increased mortality in the colder months. The association of IE with death was more significant 
in older patients, particularly in those aged 60 years old or older, and women had a higher IE specific mortality rate. Por-
tuguese demographic features can partially explain the observed outcomes. Further analysis of the epidemiology of IE in 
Portugal, especially incidence of the disease, previous comorbidities and demographics of the patients, as well as other 
socio-economic factors such as level of education and income would be crucial to expand our understanding of these find-
ings. 
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Table 1 – Demographic characteristics of patients with fatal IE be-
tween 2002- 2018, in Portugal
Characteristics n (%)
Gender
   Male 1624 (44.7)
   Female 2010 (55.3)
Age (years)*
   ≤ 19 2 (0.05)
   20 - 39 66 (1.8)
   40 - 59 316 (8.7)
   60 - 79 1534 (42)
   ≥ 80 1715 (47)
ICD 10
   I33 – Acute and subacute endocarditis 734 (20.2)
   I38 – Non specified valve endocarditis 2899 (79.8)
   I39 – Endocarditis and valve changes 1 (0.0)
* One case of unknown age


































2002 106 1.01 40 846 391.07 0.26 48 0.95 58 1.07
2003 110 1.05 40 893 390.46 0.27 59 1.17 51 0.94
2004 106 1.01 36 983 352.40 0.29 51 1.01 55 1.01
2005 141 1.34 36 570 347.89 0.39 61 1.21 80 1.47
2006 108 1.03 32 872 312.10 0.33 54 1.07 54 0.99
2007 154 1.46 34 103 323.15 0.45 69 1.36 85 1.55
2008 165 1.56 33 642 318.49 0.49 82 1.62 83 1.51
2009 199 1.88 33 314 315.07 0.60 88 1.74 111 2.01
2010 189 1.79 33 693 318.68 0.56 88 1.74 101 1.83
2011 210 1.99 31 565 299.41 0.67 97 1.92 113 2.05
2012 230 2.19 32 761 312.39 0.70 105 2.09 125 2.27
2013 280 2.69 31 421 301.33 0.89 119 2.39 161 2.94
2014 275 2.65 32 134 309.73 0.86 126 2.55 149 2.73
2015 296 2.86 32 275 312.10 0.92 114 2.32 182 3.34
2016 343 3.33 32 628 316.48 1.05 150 3.07 193 3.55
2017 332 3.23 32 180 312.70 1.03 140 2.87 192 3.54
2018 390 3.80 32 732 318.51 1.19 173 3.56 217 4.00
* Per 100 000 persons
Table 3 – Age specific proportion of deaths caused by IE per total number of deaths and IE mortality rate
Age group n Proportion IE deaths per total deaths (*100) Age specific IE mortality rate* 
≤ 19 2 0.02 < 0.0001
20 - 39 66 0.17 0.13 
40 - 59 316 0.18 0.64 
60 - 79 1534 0.24 4.30 
≥ 80 1715 0.18 17.92 
* Per 100 000 persons per year
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Table 4 – Results of negative binomial regression for the number of monthly deaths
Variable Rate ratio Lower limit Upper limit p-value
Baseline 0.048 0.036 0.065
Year* 1.086 1.077 1.094 < 0.00001
Age  [0, 39] 1 < 0.00001
        [40, 59] 9.4 7.3 12.4
        [60, 79] 45.5 35.9 58.8
        ≥ 80 48.7 38.4 62.9
Gender  Male 1 < 0.00001
              Female 1.19 1.10 1.28
Season† 1 < 0.00001
0.797 0.737 0.862
* Year is coded as a continuous variable from 1 to 17, corresponding to 2002 to 2018; † The reference season is from December to March.
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Figure 3 – Evolution of deaths due to IE in Portugal from 2002 to 2018. Standardized mortality rate (per 100 000) (purple line) and propor-
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Figure 5 – Distribution of patients concerning death location according to gender (A) and age group (B)
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